Cerus Newsroom

Cantor Fitzgerald Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsOct 31, 2024 07:31 ET

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsOct 30, 2024 23:32 ET

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Moomoo NewsOct 30, 2024 09:31 ET

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Moomoo NewsOct 29, 2024 09:31 ET

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Moomoo NewsOct 28, 2024 09:31 ET

Cerus (CERS) Gets a Buy From Craig-Hallum

TipRanksOct 28, 2024 09:30 ET

Cerus Is Maintained at Buy by Stifel

Dow JonesOct 17, 2024 10:53 ET

Cerus Analyst Ratings

BenzingaOct 17, 2024 10:43 ET

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Moomoo NewsOct 17, 2024 09:34 ET

Cerus (CERS) Gets a Buy From Craig-Hallum

TipRanksOct 17, 2024 08:47 ET

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsOct 17, 2024 08:31 ET

Stifel Maintains Cerus(CERS.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsOct 17, 2024 08:31 ET

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsOct 16, 2024 22:32 ET

Optimistic Future for Cerus: Buy Rating Despite EU Setback, Support From BARDA Boosts US Prospects

TipRanksOct 16, 2024 22:27 ET

Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating

Moomoo NewsAug 2, 2024 09:34 ET

Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)

TipRanksAug 2, 2024 09:06 ET

Stifel Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsAug 2, 2024 08:31 ET

TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsAug 2, 2024 06:36 ET

Cerus's Strong Q1 Growth and Promising INTERCEPT Technology Drive Buy Rating

TipRanksMay 5, 2024 06:50 ET

Cerus Analyst Ratings

BenzingaMay 3, 2024 11:17 ET